Equities Research Analysts’ Price Target Changes for August 9th (AKAM, ASPN, BLNK, BN, CABA, CRNX, DDOG, IDN, JANX, LAW)

Equities Research Analysts’ price target changes for Friday, August 9th:

Akamai Technologies (NASDAQ:AKAM) had its target price raised by Scotiabank from $110.00 to $115.00. Scotiabank currently has a sector outperform rating on the stock.

Aspen Aerogels (NYSE:ASPN) had its target price increased by HC Wainwright from $25.00 to $30.00. The firm currently has a buy rating on the stock.

Blink Charging (NASDAQ:BLNK) had its price target cut by HC Wainwright from $15.00 to $8.00. The firm currently has a buy rating on the stock.

Brookfield (NYSE:BN) had its target price raised by Scotiabank from $50.50 to $51.25. They currently have a sector outperform rating on the stock.

Cabaletta Bio (NASDAQ:CABA) had its target price trimmed by HC Wainwright from $30.00 to $25.00. HC Wainwright currently has a buy rating on the stock.

Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target increased by HC Wainwright from $60.00 to $69.00. HC Wainwright currently has a buy rating on the stock.

Datadog (NASDAQ:DDOG) had its price target lowered by Scotiabank from $145.00 to $135.00. The firm currently has a sector outperform rating on the stock.

Intellicheck (NYSE:IDN) had its price target cut by HC Wainwright from $5.00 to $4.00. HC Wainwright currently has a buy rating on the stock.

Janux Therapeutics (NASDAQ:JANX) had its target price reduced by Scotiabank from $47.00 to $42.00. The firm currently has a sector perform rating on the stock.

CS Disco (NYSE:LAW) had its target price trimmed by Needham & Company LLC from $11.00 to $8.00. Needham & Company LLC currently has a buy rating on the stock.

Mogo (NASDAQ:MOGO) had its price target trimmed by HC Wainwright from $8.00 to $6.00. The firm currently has a buy rating on the stock.

Nerdy (NYSE:NRDY) had its target price lowered by Needham & Company LLC from $4.00 to $2.00. Needham & Company LLC currently has a buy rating on the stock.

Phunware (NASDAQ:PHUN) had its price target reduced by HC Wainwright from $12.00 to $7.00. The firm currently has a buy rating on the stock.

Sana Biotechnology (NASDAQ:SANA) had its price target trimmed by HC Wainwright from $12.00 to $11.00. The firm currently has a buy rating on the stock.